These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30224200)

  • 21. A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model.
    Strohmeier S; Amanat F; Zhu X; McMahon M; Deming ME; Pasetti MF; Neuzil KM; Wilson IA; Krammer F
    mBio; 2021 Dec; 12(6):e0224121. PubMed ID: 34809451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing perspective on immunization against influenza.
    Johansson BE; Brett IC
    Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.
    Kilbourne ED; Smith C; Brett I; Pokorny BA; Johansson B; Cox N
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10748-52. PubMed ID: 12136133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.
    Ross TM
    J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza Hemagglutinin and Neuraminidase: Yin⁻Yang Proteins Coevolving to Thwart Immunity.
    Kosik I; Yewdell JW
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31014029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.
    Dai M; Du W; Martínez-Romero C; Leenders T; Wennekes T; Rimmelzwaan GF; van Kuppeveld FJM; Fouchier RAM; Garcia-Sastre A; de Vries E; de Haan CAM
    mBio; 2021 May; 12(3):. PubMed ID: 33975931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
    Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
    Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
    Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
    Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
    Ning T; Nie J; Huang W; Li C; Li X; Liu Q; Zhao H; Wang Y
    J Infect Dis; 2019 Jan; 219(1):19-25. PubMed ID: 29982588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection.
    Wong SS; Waite B; Ralston J; Wood T; Reynolds GE; Seeds R; Newbern EC; Thompson MG; Huang QS; Webby RJ;
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody Determinants of Influenza Immunity.
    Crowe JE
    J Infect Dis; 2019 Apr; 219(Suppl_1):S21-S29. PubMed ID: 30715373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the emergence of H3N2 influenza viruses reveals contrasted modes of evolution of HA and NA antigens.
    Sandie R; Aris-Brosou S
    J Mol Evol; 2014 Jan; 78(1):1-12. PubMed ID: 24343641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses.
    Saxena SK; Mishra N; Saxena R; Swamy ML; Sahgal P; Saxena S; Tiwari S; Mathur A; Nair MP
    J Infect Dev Ctries; 2009 Nov; 4(1):1-6. PubMed ID: 20130371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.
    Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y
    Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase.
    Gnirß K; Zmora P; Blazejewska P; Winkler M; Lins A; Nehlmeier I; Gärtner S; Moldenhauer AS; Hofmann-Winkler H; Wolff T; Schindler M; Pöhlmann S
    J Virol; 2015 Sep; 89(18):9178-88. PubMed ID: 26109730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
    Eichelberger MC; Monto AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.